Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
72.45
-1.32 (-1.79%)
At close: Sep 14, 2026, 4:00 PM EDT
73.00
+0.55 (0.76%)
After-hours: Sep 14, 2026, 7:30 PM EDT

Cytokinetics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Maintains
$112
BuyMaintains$112+54.59%Sep 10, 2026
Truist Financial
Truist Financial
Buy
Reiterates
$112
BuyReiterates$112+54.59%Sep 1, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$100
BuyMaintains$100+38.03%Aug 31, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
$85
HoldMaintains$85+17.32%Aug 31, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$140
BuyReiterates$140+93.24%Aug 31, 2026
Needham
Needham
Buy
Maintains
$112
BuyMaintains$112+54.59%Aug 28, 2026
Goldman Sachs
Goldman Sachs
Buy
Reiterates
$105
BuyReiterates$105+44.93%Aug 28, 2026
Barclays
Barclays
Buy
Reiterates
$110
BuyReiterates$110+51.83%Aug 27, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.